Enanta Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Enanta Pharmaceuticals

10/02/2025 22:02

* Enanta Pharmaceuticals Inc  ENTA.OQ  reported a quarterly
adjusted loss of $1.05​​ per share for the quarter ended
December 31, higher than the same quarter last year, when the
company reported EPS of $-1.58.  The mean expectation of
five analysts for the quarter was for a loss of $1.35 per share.
Wall Street expected results to range from $-1.50 to $-1.16 per
share.
    * Revenue fell 5.8% to $16.96 million from a year ago;
analysts
expected $17.25 million. 
    * Enanta Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.05​.
    * The company reported a quarterly loss of $22.29 million.
    * Enanta Pharmaceuticals Inc shares had fallen by 14.8% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 15.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Enanta
Pharmaceuticals Inc is $19.00 
This summary was machine generated from LSEG data February 10 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -1.35          -1.05          Beat
 Sep. 30 2024      -1.16          -1.36          Missed
 Jun. 30 2024      -1.45          -1.07          Beat
 Mar. 31 2024      -1.30          -1.47          Missed